UCB is a global biopharmaceutical company, with a focus on neurology and immunology.
Our business is strong. Total revenue grew to €4.2 billion in 2016. We are more than 7,700 people in all four corners of the globe, inspired by patients and driven by science.
Looking ahead, we have a solid platform for continuous growth with our core products Cimzia, Vimpat, Neupro, Keppra and Briviact, and we are preparing the launch of a potential medicine to help patients with osteoporosis. At the same time, we are very excited about the progress in our early research pipeline.
Description
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. In order to deliver the best solutions to patients, we are currently seeking a
(Senior) Manager Health Economics/Outcomes Research, Immunology/Bone
As the successful candidate for this key role, you will hold responsibility for the design, development and implementation of health economics and/or health outcomes research strategies and projects to demonstrate the payer value of various compounds of UCBs late stage and in-market portfolio in the Immunology and Bone Disease area.
Your responsibilities are to:
Your profile:
Please apply with your CV and cover letter by the 'apply' button below.
Please use "Qreer.com" as reference in your application.
Education Backgrounds: |
Biomedical Science Chemical Engineering Healthcare Science |
Specialties: |
Biomedical Engineering Life sciences Research (R&D) |
Education Level: |
Postgraduate (Masters) Doctorate (PH.D) |
Experience: |
10 - 15 years 5 - 10 Years > 15 years |
Languages spoken: |
English |
Job Location: | Bruxelles, Belgium |
Type: Job
Deadline: 29th October 2013
Job reference (ID): 6308
Loading...